Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Receives $3.2M Milestone from GSK Under Vaccine Collaboration
August 02, 2012
Alnylam Receives $3.2M Milestone from GSK Under Vaccine Collaboration
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Isis to Receive $1.1M from Alnylam
October 25, 2012 / Gene Silencing News
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 22, 2013 / Gene Silencing News
Alnylam Releases Proof-of-concept Data on Preclinical Porphyria Drug
May 21, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 21, 2013 / Gene Silencing News
Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News